CIDRAP newsletters options
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
Even countries that managed earlier outbreaks well face surges, and officials say they're tracking the variant fueling India's rise.
In-hospital COVID death rates are declining, but the virus still poses substantial risk, including a doubled death rate in surgical patients.
Secondary analysis of patients from a postdischarge decolonization trial of methicillin-resistant Staphylococcus aureus (MRSA) carriers found that re-hospitalization for MRSA was associated with extensive exposure to non-MRSA antibiotics and Clostridioides difficile infection (CDI), researchers reported today in Infection Control & Hospital Epidemiology.
UK researchers have uncovered the novel mechanism behind rare abnormal blood clotting seen in some AstraZeneca/Oxford vaccine recipients, according to a study today in the New England Journal of Medicine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
"This has put Brazil in a permanent state of mourning and led to the near collapse of Brazil's health system."
Only 2 of the 11 antibiotics approved since 2017 represent a novel class, and the pipeline is insufficient to counter rising resistance, experts say.
COVID-19 poses 8 to 10 times the risk of blood clots in the brain than do COVID vaccines, a preprint study finds.
About 43% of Republicans, 5% of Democrats, and 22% of Independents say no to the vaccine.
The P1 SARS-CoV-2 variant, which was first identified in Brazil, may be more than twice as transmissible as non-P.1 lineages, and it may lower protective immunity from non-P1 variants 21% to 46%, according to a study published yesterday in Science.
A study of antibodies in 48 people in Saudi Arabia who survived their MERS-CoV infections found that some neutralizing antibodies persisted 6 years, a Saudi-led team reported yesterday in Emerging Infectious Diseases.
"Exercise is medicine that everyone should take—especially in this era of COVID-19."
ACIP experts will gather more data and likely meet again in 7 to 10 days.
PAHO's director says South America continues to be an epicenter but is not acting like it by easing mitigations steps.
A pilot trial conducted at two emergency departments (EDs) found that audit and feedback with peer-to-peer comparisons reduced antibiotic prescribing for viral acute respiratory infections (ARIs) but not overall antibiotic use, researchers reported today in Open Forum Infectious Diseases.
Keeping middle seats vacant on air flights has the potential to cut transmission of virus particles by 57% when multiple passengers are infected and by 23% when a single passenger is infected, according to an aerosol dispersion study that included earlier data that modeled plane airflow.
Studies find that antibodies pass robustly from mothers to infants in breast milk.
Spikes continue in hot spots like Iran and Japan as the global death toll nears 3 million.
"Right now I'd like to stress these events seem to be extremely rare," says Janet Woodcock, acting FDA commissioner.
